Regulatory News: BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices, presents its financial reporting schedule for 2023 (1) . Annonce Date* 2022 full-year results Thursday, April 6 th , 2023 Before the market opening Annual shareholders meeting Tuesday, May 16 th , 2023 2023 first-half results Thursday, September 28 th , 2023 Before the market opening (1) This schedule is...